What should uro-oncologist know about new drugs in 2017?
by Morgan Roupret
When can checkpoint inhibitors be used to treat urothelial carcinoma?
by Joaquim Bellmunt
Are bladder sparing procedures a real advancement in muscle invasive bladder cancer?
by Anne Kiltie
CABOSUN trial of cabozantinib - could it change how we treat frontline RCC?
by Toni Choueiri
Using checkpoint inhibitors at earlier stages of bladder cancer – the next step in immunotherapy?
by Thomas Powles